Skip to content
TGA: interim scheduling decisions (Australia)·AI score48

TGA extends comment deadline to 31 July 2026 on interim decision on psilocybine Poisons Standard amendment from ACMS #47

Notice of interim decision on proposed amendment to the Poisons Standard in relation to psilocybine - ACMS #47 - June 2025

AI summary

The TGAThe Therapeutic Goods Administration, Australia's national regulator of medicines and medical devices.Open the glossary has extended the closing date for comment on its interim decision on a proposed amendment to the Poisons StandardThe Australian legal instrument that sorts medicines and chemicals into schedules, which set how each can be supplied.Open the glossary concerning psilocybine, from ACMS #47, to 31 July 2026. The interim decision follows the June 2025 advisory committee meeting.

Key facts

Compound
Psilocybin
Jurisdiction
Australia
Source
TGA: interim scheduling decisions (Australia) (tga.gov.au)
Published
How this summary was made

The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method

Source: TGA: interim scheduling decisions (Australia) · tga.gov.au

Connected to

Compound
Psilocybin
Jurisdiction
Australia

Other recent items on these topics